Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-33,154
Closed -$1.33M 804
2015
Q4
$1.33M Buy
33,154
+1,434
+5% +$65.8K 0.01% 729
2015
Q3
$1.63M Sell
31,720
-900
-3% -$59.7K 0.01% 719
2015
Q2
$2.59M Sell
32,620
-133
-0.4% -$11.3K 0.02% 676
2015
Q1
$2.69M Buy
32,753
+8,379
+34% +$702K 0.02% 696
2014
Q4
$2.16M Buy
24,374
+52
+0.2% +$4.71K 0.02% 704
2014
Q3
$2.38M Buy
+24,322
New +$2.73M 0.02% 695

Other funds holding ENOV

Aviva's ENOV Position: Q1 2016 in Review

Aviva sold out of Enovis (ENOV) in Q1 2016, closing a stake of 33,154 shares — an estimated $1.33M sold.

Aviva first reported a position in ENOV in Q3 2014 and held it in 6 quarters. The position peaked at $2.69M in Q1 2015. 194 funds tracked by Wall St. Rank hold ENOV as of Q1 2016.

  • Aviva reported no remaining Enovis position as of Q1 2016 after selling out during the quarter.
  • Aviva sold 33,154 Enovis shares in Q1 2016, an estimated $1.33M.
  • Aviva first reported a position in Enovis in Q3 2014 and held it in 6 quarters.
  • Aviva's Enovis position peaked at $2.69M in Q1 2015.
  • 194 funds tracked by Wall St. Rank held Enovis as of Q1 2016.

Based on Aviva's 13F filing for Q1 2016, filed 12 May 2016.